Revelation Biosciences, Inc. ( REVB) - Key Metrics
REVB Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q2 | $0 | -$0.87 | -$0.67 | -$0.68 |
| 2026Q1 | $0 | -$0.94 | -$1 | -$1.02 |
| 2025Q4 | $0 | -$4.04 | -$3.17 | -$3.17 |
| 2025Q3 | $0 | -$0.72 | -$0.60 | -$0.60 |
| 2025Q2 | $0 | -$3.05 | -$2.39 | -$2.39 |
REVB Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q2 | 0% | -0.30 |
| 2026Q1 | 0% | -0.11 |
| 2025Q4 | 0% | -0.48 |
| 2025Q3 | 0% | -0.80 |
| 2025Q2 | 0% | -0.32 |
REVB
Price: $1.11
52 week price:
Earnings Per Share: 26.55 USD
P/E Ratio: 0.04
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 562000
Market Capitalization: 4.3 million